Royal Fund Management, LLC Pfizer Inc Transaction History

Royal Fund Management, LLC

$941 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $1,544 - $2,016	-37 Reduced 0.72%	5,094 $0
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $16,147 - $19,711	369 Added 7.75%	5,131 $224,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $25,172 - $29,846	541 Added 12.82%	4,762 $249,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $4,437 - $5,498	97 Added 2.35%	4,221 $218,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $170,403 - $252,595	4,124 New	4,124 $243,000
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $205,552 - $264,049	-5,237 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $188,060 - $213,041	5,237 New	5,237 $205,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $212,594 - $239,763	-6,348 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $29,754 - $37,835	889 Added 16.29%	6,348 $233,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $173,323 - $203,347	5,459 New	5,459 $200,000
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $119,425 - $144,881	-3,965 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $1.11 Million - $1.59 Million	-41,202 Reduced 91.22%	3,965 $129,000
Q4 2019 May 11, 2020	SELL	$32.92 - $37.36 $293,086 - $332,616	-8,903 Reduced 16.47%	45,167 $1.77 Million
Q3 2019 May 08, 2020	SELL	$32.49 - $42.13 $2.71 Million - $3.51 Million	-83,276 Reduced 60.63%	54,070 $1.94 Million
Q2 2019 May 08, 2020	BUY	$36.98 - $41.52 $199,359 - $223,834	5,391 Added 4.09%	137,346 $5.95 Million
Q1 2019 May 11, 2020	BUY	$37.5 - $41.2 $4.19 Million - $4.61 Million	111,846 Added 556.2%	131,955 $5.6 Million
Q4 2018 May 07, 2020	SELL	$38.47 - $43.86 $27,506 - $31,359	-715 Reduced 3.43%	20,109 $877,000
Q3 2018 May 07, 2020	SELL	$34.47 - $41.81 $15,683 - $19,023	-455 Reduced 2.14%	20,824 $917,000
Q2 2018 May 07, 2020	SELL	$32.98 - $35.16 $50,162 - $53,478	-1,521 Reduced 6.67%	21,279 $772,000
Q1 2018 May 07, 2020	SELL	$31.91 - $37.02 $16,369 - $18,991	-513 Reduced 2.2%	22,800 $809,000
Q4 2017 May 07, 2020	SELL	$33.26 - $35.29 $25,477 - $27,032	-766 Reduced 3.18%	23,313 $844,000
Q3 2017 May 07, 2020	SELL	$31.0 - $34.15 $137,361 - $151,318	-4,431 Reduced 15.54%	24,079 $859,000
Q2 2017 May 07, 2020	SELL	N/A	-143 Reduced 0.5%	28,510 $957,000
Q1 2017 May 07, 2020	SELL	N/A	-2,784 Reduced 8.86%	28,653 $980,000
Q4 2016 May 07, 2020	BUY	N/A	31,437	31,437 $1.02 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Account